Skip to main content
Premium Trial:

Request an Annual Quote

Nanostream Gets $22M Series C Financing

NEW YORK, June 4 - Pasadena, Calif.-based Nanostream, a microfluidics developer, today announced $22 million in Series C funding.


The company said the round was lead by AEA Investors -- a New York firm created in 1969 to invest funds of the Rockefellers, Mellons and Harrimans -- and Lilly BioVentures, the venture capital arm of Eli Lilly.


Other investors included: Techno Venture Management of Munich, Germany, and Flagship Ventures of Cambridge, Mass., as well as private investors who had participated in previous funding rounds of $11 million.


Founded in 1999, the company manufactures a system of instruments, microfluidics cartridges, and software.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.